☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
breast cancer
Accent Therapeutics Receives the US FDA’s IND Approval of ATX-559 for Treating Breast Cancer
October 25, 2024
Daiichi Sankyo Reports the sNDA Submission of Enhertu to Treat HER2 Low or Ultralow Metastatic Breast Cancer in Japan
October 4, 2024
Key Biosimilars Events of September 2024
October 4, 2024
Organon and Shanghai Henlius Biotech Provides Update on P-III Trial of HLX11 (Biosimilar, Perjeta)
September 30, 2024
Genentech Reports the Acquisition of Regor's CDK Inhibitors Portfolio Targeting Breast Cancer
September 30, 2024
AstraZeneca and Daiichi Sankyo Provide Update on the P-III (TROPION-Breast01) Study of Datopotamab Deruxtecan to Treat Breast Canc...
September 23, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.